Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia
- PMID: 38700565
- PMCID: PMC11068715
- DOI: 10.1186/s12348-024-00397-y
Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia
Abstract
Purpose: To report the use of Fluocinolone intravitreal implant (Iluvien) for the treatment of persistent cystoid macular edema (CME) due to immune recovery uveitis syndrome in a patient with previous cytomegalovirus retinitis and acute myeloid leukemia.
Design: Case report.
Methods: The clinical history of a patient who received an Iluvien implant in one eye for the treatment of cystoid macular edema due to immune recovery uveitis syndrome, previously treated with peribulbar Triamcinolone and intravitreal Dexamethasone injections, was reviewed.
Results: A 48-year-old woman presented with cystoid macular edema due to immune recovery uveitis syndrome. The patient had a history of cytomegalovirus retinitis 3.5 years prior, secondary to immunosuppressive treatment for an acute myeloid leukemia. Three periocular triamcinolone injections and two dexamethasone intravitreal implants were performed, but the edema recurred, so fluocinolone intravitreal implant was used, achieving a sustained control of the condition at one year of follow-up.
Conclusion: The Fluocinolone intravitreal implant may be an effective treatment for persistent CME in patients with immune recovery uveitis syndrome.
Keywords: Cystoid macular edema; Cytomegalovirus retinitis; Fluocinolone intravitreal implant; Immune recovery uveitis; Uveitis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.Eur J Ophthalmol. 2023 Jan;33(1):NP23-NP27. doi: 10.1177/11206721211046718. Epub 2021 Nov 26. Eur J Ophthalmol. 2023. PMID: 34836464
-
SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS.Retin Cases Brief Rep. 2024 Jul 1;18(4):421-427. doi: 10.1097/ICB.0000000000001404. Retin Cases Brief Rep. 2024. PMID: 36657153 Free PMC article.
-
Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.Int Med Case Rep J. 2021 Feb 26;14:127-132. doi: 10.2147/IMCRJ.S295045. eCollection 2021. Int Med Case Rep J. 2021. PMID: 33664598 Free PMC article.
-
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review.J Ophthalmol. 2021 May 17;2021:6678364. doi: 10.1155/2021/6678364. eCollection 2021. J Ophthalmol. 2021. PMID: 34055398 Free PMC article. Review.
-
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema.Drugs. 2017 Apr;77(5):575-583. doi: 10.1007/s40265-017-0722-4. Drugs. 2017. PMID: 28283896 Review.
References
-
- Kuo, Irene C. et al. Clinical Characteristics and Outcomes of Cytomegalovirus Retinitis in Persons Without Human Immunodeficiency Virus Infection. American Journal of Ophthalmology 2004; 138:338–346. DOI:10.1016/j.ajo.2004.04.015. - PubMed
-
- Hidrón, Alicia et al. Síndrome inflamatorio de reconstitución inmune en pacientes infectados con VIH y afecciones fúngicas. Infectio. 2012; 16(Supl 3): 51–58. DOI:10.1016/S0123-9392(12)70027-9.
-
- Hu, Jianmin et al. Fluocinolone Acetonide Implant (Retisert) for Chronic Cystoid Macular Edema in Two Patients with AIDS and a History of Cytomegalovirus Retinitis. Ocular Immunology & Inflammation, 19(3), 206–209, 2011. DOI:10.3109/09273948.2010.538120. - PubMed
-
- Baker, Michelle L et al. Immune recovery uveitis in an HIV-negative individual. Letters to the Editor. Journal compilation 2007, Royal Australian and New Zealand College of Ophthalmologists. DOI:10.1111/j.1442-9071.2006.01439.x.
LinkOut - more resources
Full Text Sources